LAURUSLABS — Laurus Labs Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Laurus Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	49,356	60,406	50,408	55,540	68,129
Cost of Revenue
Gross Profit	24,828	28,757	22,036	26,912	36,781
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	37,617	47,469	46,460	49,288	55,073
Operating Profit	11,739	12,936	3,949	6,252	13,056
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	10,839	11,089	2,364	4,843	11,819
Provision for Income Taxes
Net Income After Taxes	8,324	7,966	1,682	3,544	8,899
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	8,275	7,901	1,606	3,583	8,888
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	8,275	7,901	1,606	3,583	8,888
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	15.4	14.6	3	5.87	16.5
Dividends per Share